Form D · Biotechnology
Bioscience Americas, LLC
Phoenix, AZ · CIK 0001648864
Offering snapshot reported Oct 26, 2017 · SEC filing
- Reported sold
- $4.77M Offering amount: $15M
- Investors reported
- 63 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Oct 28, 2015 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$950,000 → $4,771,512
- Reported investors15 → 63
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2017 | Amendment | $4,771,512 | $3,821,512vs Nov 3, 2016 | 63 | SEC filing |
| Nov 3, 2016 | Amendment | $950,000 | $830,000vs Nov 9, 2015 | 15 | SEC filing |
| Nov 9, 2015 | Initial | $120,000 | No comparison | 3 | SEC filing |
| Jul 22, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $50K
- Form D file number
- 021-250885
Source: Form D, filed Oct 26, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
HARK CAPITAL II PARALLEL, LP
Investment adviser: ENHANCED CAPITAL PARTNERS, LLC
- Gross asset value
- $136M
- Beneficial owners
- 3
- ADV minimum commitment
- $0
Reported in Form ADV on Mar 30, 2018. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- No
RSM US, LLP
PCAOB 49
Filing source
Form ADV 1182124 · Mar 30, 2018 · Schedule D 7.B.(1), fund 805-6333555704
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Cullen Stoffers | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Phoenix, AZ, 85016